Lv11
60 积分 2026-08-25 加入
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
28天前
已完结
Abstract 5233: Increased galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic cancer via suppressing oxidated phosphorylation
1个月前
已完结
Long non‑coding SBF2‑AS1 acting as a competing endogenous RNA to sponge microRNA‑142‑3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1
2个月前
已完结
皖公网安备34019202002308
